Table 3.
In-hospital event rates and logistic regression models for mortality and acute stent thrombosis by CHA2DS2-VASc score
| CHA2DS2-VASc score |
|||||||
|---|---|---|---|---|---|---|---|
| 1 (n = 1,392) | 2 (n = 979) | 3 (n = 598) | 4 (n = 352) | 5 (n = 112) | 6 (n = 12) | 7 (n = 13) | |
| In-hospital mortality, n (%) Mortality | 10 (0.7) | 22 (2.2) | 47 (7.9) | 34 (9.7) | 17 (15.2) | 2 (16.7) | 4 (30.8) |
| Model 1: unadjusted | 1 (reference) | 3.1 (1.4–6.7) | 11.7 (5.9–23.4) | 14.7 (7.2–30.2) | 24.7 (11.0–55.4) | 27.6 (5.3–142) | 61.4 (16.2–232) |
| Model 2: adjusted for all covariatesa | 1 (reference) | 1.6 (0.6–4.2) | 2.3 (1.8–8.3) | 2.8 (1.9–9.3) | 4.3 (2.6–10.4) | 6.2 (4.6–21.6) | 39.2 (13.2–116) |
| Acute stent thrombosis events, n (%) Events | 22 (1.6) | 32 (3.3) | 23 (3.8) | 27 (7.6) | 16 (14.3) | 7 (58.8) | 9 (69.3) |
| Model 1: unadjusted | 1 (reference) | 2.1 (1.2–3.6) | 2.4 (1.3–4.5) | 5.1 (2.8–9.1) | 10.3 (5.2–20.4) | 87.1 (25.5–296) | 140 (40.1–489) |
| Model 2: adjusted for all covariatesa | 1 (reference) | 1.8 (1.1–4.1) | 2.0 (1.5–5.8) | 4.3 (2.4–7.7) | 8.3 (4.1–14.6) | 36.2 (12.4–136) | 96.3 (29.4–236) |
Values are presented as OR (95% CI) unless otherwise stated.
a
Includes demographics (age and sex), smoking, comorbidities (hypertension, diabetes mellitus, hyperlipidemia, chronic kidney disease, peripheral arterial disease, and stroke), Killip class, anterior myocardial infarction, stent diameter, stent length and no-reflow.